A private wealth investment firm based in Europe focuses on investing in digital health, devices and diagnostics technologies. Though an early investor, the firm looks for companies that have some proof of concept data. The firm primarily invests in companies within the country where the firm is based, but will consider investments in North America, all of Europe and Israel. The firm generally looks to invest between 100K-2M EUR in their portfolio companies.
The firm will invest in digital health as well as diagnostics and devices as well as regenerative medicine technologies. For diagnostics and devices, the firm prefers companies with a digital component. In addition, the firm prefers devices without complex regulatory requirements. The firm is agnostic with regards to indication.
The firm is willing to lead or co-invest, although they are most likely to lead if investing in Hungary. Generally, the firm prefers to have a board or an observer seat after investing. Within the life sciences, the firm prefers to invest in teams with industry experience, especially for companies located outside of the country where the firm is based.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment